Brachytherapy + External Beam Radiotherapy (EBRT) + NIMOTUZUMAB + CISPLATIN for uterine cervical neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Mar 2024: Trial registered, NCT06333821

The trials

NCT06333821: A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma

State
Not started
Phase
Phase 3
People
460 planned
Started
1 Apr 2024
Primary completion
1 Apr 2030
Arms
Nimotuzumab+chemoradiotherapy
Results
None posted
  1. 27 Mar 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.